ChromaDex Reports Second Quarter 2017 Financial Results
Aug 10, 2017 20:05 pm UTC| Business
-Company Reports Revenue of $5.3 Million for Q2 2017- - Continued Progress on Building a Consumer Products Platform Around TruNiagen®- IRVINE, Calif., Aug. 10, 2017 -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of...
Aug 10, 2017 20:04 pm UTC| Business
STEVENSON, Md., Aug. 10, 2017 -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the...
Aug 10, 2017 20:03 pm UTC| Business
STEVENSON, Md., Aug. 10, 2017 -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the...
Aug 10, 2017 20:01 pm UTC| Business
Q2 2017 revenues of $25.7 million, up 168% over $9.6 million for Q2 2016Q2 2017 product sales of $12.7 million, up 159% over $4.9 million for Q2 2016Completed equity financing and exceeded target with $103 million in total...
Chiasma Reports Second Quarter 2017 Results
Aug 10, 2017 20:01 pm UTC| Business
WALTHAM, Mass., Aug. 10, 2017 -- Chiasma, Inc. (NASDAQ:CHMA), a clinical-stage biopharmaceutical company focused on improving the lives of patients with rare and serious chronic diseases, today reported financial...
STRATA Skin Sciences Reports Second Quarter 2017 Financial Results
Aug 10, 2017 20:01 pm UTC| Business
HORSHAM, Pa., Aug. 10, 2017 -- (NASDAQ:SSKN) STRATA Skin Sciences, Inc. (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative...
AveXis Reports Second Quarter 2017 Financial and Operating Results
Aug 10, 2017 20:01 pm UTC| Business
– AveXis on track to submit potency assay data to FDA in August – – Conference call and webcast August 10 at 4:30 p.m. EDT – CHICAGO, Aug. 10, 2017 -- AveXis, Inc. (NASDAQ:AVXS), a clinical-stage gene therapy...